Calanolide A
Sponsors
Sarawak MediChem Pharmaceuticals
Conditions
HIV Infections
Phase 1
The Safety and Effectiveness of (+)-Calanolide A in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
NCT00005120
Start: 2000-04-30Target: 16Updated: 2005-06-24
A Study to Evaluate the Safety and Effectiveness of a New Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI), (+)-Calanolide A, in HIV-Positive Patients Who Have Never Received Anti-HIV Treatment
CompletedNCT00002243
Target: 32Updated: 2005-06-24